The EESC believes that evidence based processes like Health Technology Assessment (HTA) that is a key driver for socio-economic growth and innovation in the Union can be achieved through cooperation between Member States at Union level aiming at a high protection of health for patients and ensuring the smooth functioning of an inclusive Single Market. It is concerned about the set timelines of implementation and especially the delayed application of three years and believes that for the benefit of the patients and cost-effectiveness this could be shortened. In order to achieve the promise of digital health and care, of which HTA is part, the involvement of civil society is crucial.
Social economy is a key and a growing contributor to the European economy and the job creation.
This exploratory opinion has been requested by the Portuguese presidency of the Council. Social economy represents a key and a growing contributor to the European economy and the job creation. It has a positive impact on working conditions and the enlargement of the labour market. Social economy has a pivotal role to play in the future Action plan for the implementation of the European Pillar of Social Rights by promoting social inclusion and a better access to the labour market.
The landscape of digital services is significantly different today from 20 years ago, when the eCommerce Directive was adopted. Online intermediaries have become vital players in the digital transformation. Online platforms in particular have created significant benefits for consumers and innovation, but at the same time, they can be used as a vehicle for disseminating illegal content, or selling illegal goods or services online.
In its opinion, the EESC calls for physical and digital completion of the internal market to be on an equal footing and for a high level of consumer protection to be achieved. It calls for greater durability of goods, access to sustainable products, a clean, circular, more climate-friendly economy and efficient use of products, as well as combating of planned obsolescence and the right to repair goods and products.
The Commission proposes a new pharmaceutical strategy for Europe. It is a patient-centred strategy that aims to ensure the quality and safety of medicines, while boosting the sector’s global competitiveness. The EU needs to make sure that patients have access to high-quality, effective and safe medicines. It will foster patient access to innovative and affordable medicines. It will support the competitiveness and innovative capacity of the EU’s pharmaceutical industry.
The EESC stresses the crucial importance of having effective training systems and the ability to anticipate skills needs at a time of profound upheavals due to the COVID-19 crisis. The EESC considers the social partners to be effective players in designing and managing training systems. They are very well placed to measure the skills needs of the labour market and must systematically play a major role in the development of qualifications and their content.
The EESC recommends drawing up national strategic agreements on vocational training and guidance, on the basis of negotiations between the authorities and the social partners, involving vocational education and training stakeholders.
The EU chemicals strategy aims to address the cumulative and combined effects of chemicals, including pesticides, stressing a need to accelerate work on methodologies that ensure existing provisions can be fully implemented.
The strategy is intended as a first step towards a zero pollution ambition for a toxic-free environment, as announced in the European Green Deal.
The Communication stresses the EU's commitment to safeguarding an online environment providing the highest possible freedom and security, for the benefit of its citizens.